Foster City, CA, Gilead Sciences Inc. (Nasdaq: GILD) today announced it is voluntarily recalling two lots of Veklury® (remdesivir 100 mg for injection) to the user level.
Not diminishing the recall, but I don’t know how much “two lots” accounts for, and it seems that my dad is set on his decision…he’s currently receiving his second intravenous drip
Not diminishing the recall, but I don’t know how much “two lots” accounts for, and it seems that my dad is set on his decision…he’s currently receiving his second intravenous drip